BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 309301)

  • 1. Behavioral evidence for denervation supersensitivity after destruction of central serotonergic nerve terminals.
    Trulson ME; Jacobs BL
    Ann N Y Acad Sci; 1978 Jun; 305():497-509. PubMed ID: 309301
    [No Abstract]   [Full Text] [Related]  

  • 2. Behavioral evidence for supersensitivity following destruction of central serotonergic nerve terminals by 5,7-dihydroxytryptamine.
    Trulson ME; Eubanks EE; Jacobs BL
    J Pharmacol Exp Ther; 1976 Jul; 198(1):23-32. PubMed ID: 132525
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Behavioral evidence for the stimulation of CNS serotonin receptors by high doses of LSD.
    Trulson ME; Ross CA; Jacobs BL
    Psychopharmacol Commun; 1976; 2(2):149-64. PubMed ID: 136010
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effects of some drugs affecting brain 5-HT on the aggressive behaviour and spontaneous electrical activity of the central nervous system of the ant, Formica rufa.
    Kostowski W; Tarchalska B
    Brain Res; 1972 Mar; 38(1):143-9. PubMed ID: 4536925
    [No Abstract]   [Full Text] [Related]  

  • 5. Participation of serotonin in development of morphine dependence in mice and rats.
    Kruszewska A
    Pol J Pharmacol Pharm; 1980; 32(5):655-63. PubMed ID: 6973754
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Experimental data for interaction of morphine and serotoninergic substances and their action upon some CNS-functions.
    Ovtcharov R
    Acta Physiol Pharmacol Bulg; 1982; 8(1-2):64-70. PubMed ID: 6214924
    [No Abstract]   [Full Text] [Related]  

  • 7. Developmental plasticity of central serotonin neurons after 5,7-dihydroxytryptamine treatment.
    Jonsson G; Pollare T; Hallman H; Sachs C
    Ann N Y Acad Sci; 1978 Jun; 305():328-45. PubMed ID: 280250
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lisuride and LSD: dopaminergic and serotonergic interactions in the "serotonin syndrome".
    Silbergeld EK; Hruska RE
    Psychopharmacology (Berl); 1979 Nov; 65(3):233-7. PubMed ID: 117494
    [No Abstract]   [Full Text] [Related]  

  • 9. Action of serotoninmimetics in the behavioral despair test in rats.
    Górka Z; Wojtasik E; Kwiatek H; Maj J
    Commun Psychopharmacol; 1979; 3(3):133-6. PubMed ID: 315302
    [No Abstract]   [Full Text] [Related]  

  • 10. Receptor mechanisms in increased sensitivity to serotonin agonists after dihydroxytryptamine shown by electronic monitoring of muscle twitches in the rat.
    Stewart RM; Campbell A; Sperk G; Baldessarini RJ
    Psychopharmacology (Berl); 1979 Feb; 60(3):281-9. PubMed ID: 108706
    [No Abstract]   [Full Text] [Related]  

  • 11. Behavioral and prolactin responses to 5-hydroxytryptophan in rats treated during development with 5,7-dihydroxytryptamine.
    Breese GR; Vogel RA; Kuhn CM; Mailman RB; Mueller RA; Schanberg SM
    Brain Res; 1978 Oct; 155(2):263-75. PubMed ID: 308387
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serotonin: a possible mediator of behavioral suppression induced by anxiety.
    Wise CD; Berger BD; Stein L
    Dis Nerv Syst; 1970 Nov; 31():Suppl:34-7. PubMed ID: 5312689
    [No Abstract]   [Full Text] [Related]  

  • 13. Effect of 5,7-dihydroxytryptamine on serotonergic control of prolactin secretion and behavior in rats.
    Kuhn CM; Vogel RA; Mailman RB; Mueller RA; Schanberg SM; Breese GR
    Psychopharmacology (Berl); 1981; 73(2):188-93. PubMed ID: 6785814
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Electrophysiological investigations on the effect of repeated zimelidine administration on serotonergic neurotransmission in the rat.
    Blier P; De Montigny C
    J Neurosci; 1983 Jun; 3(6):1270-8. PubMed ID: 6304261
    [No Abstract]   [Full Text] [Related]  

  • 15. 5,7-Dihydroxytryptamine as a tool to study the functional role of central 5-hydroxytryptamine neurons.
    Fuxe K; Ogren SO; Agnati LF; Jonsson G; Gustafsson JA
    Ann N Y Acad Sci; 1978 Jun; 305():346-69. PubMed ID: 280251
    [No Abstract]   [Full Text] [Related]  

  • 16. Supersensitivity to L-5-hydroxytryptophan after 5,7-dihydroxytryptamine injections in desmethylimipramine- and nomifensine-pretreated rats: behavioral evidence for postsynaptic supersensitivity.
    Ortmann R; Martin S; Waldmeier PC
    Psychopharmacology (Berl); 1981; 74(2):109-14. PubMed ID: 6115443
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evidence that serotonin mediates some behavioral effects of amphetamine.
    Sloviter RS; Drust EG; Connor JD
    J Pharmacol Exp Ther; 1978 Aug; 206(2):348-52. PubMed ID: 308099
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Denervation supersensitivity to 5-hydroxytryptophan in rats following spinal transection and 5,7-dihydroxytryptamine injection.
    Barbeau H; Bédard P
    Neuropharmacology; 1981 Jun; 20(6):611-6. PubMed ID: 6972494
    [No Abstract]   [Full Text] [Related]  

  • 19. Effects of drugs influencing serotonergic mechanisms on behaviour of insects.
    Tarchalska-Kryńska B; Kostowski W
    Pol J Pharmacol Pharm; 1976; 28(6):635-9. PubMed ID: 138133
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A common mechanism for lysergic acid, indolealkylamine and phenethylamine hallucinogens: serotonergic medication of behavioral effects in rats.
    Sloviter RS; Drust EG; Damiano BP; Connor JD
    J Pharmacol Exp Ther; 1980 Aug; 214(2):231-8. PubMed ID: 6104720
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.